Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
MAC.MDM.complement_resolving: Meta traits — page 6
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 1,931 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 5,001–5,288 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 5001 | IGFBP4 levels | PROLV001031 | 3.45e-03 | Protein levels | Renal epithelium | 3 | 0 | 6 | 7 | |
| 5002 | Pneumonopathy | RESPI000016 | 3.44e-03 | Respiratory | Pancreatic epithelium | 0 | 0 | 5 | 13 | |
| 5003 | Neurofibromatosis | NEURO000024 | 3.39e-03 | Neurologic | Lymphocyte | 0 | 3 | 13 | 23 | |
| 5004 | KIF22 levels | PROLV001139 | 3.37e-03 | Protein levels | B / plasma cell | 35 | 2 | 5 | 11 | |
| 5005 | RSPO1/RSPO3 ratio | PRORT001750 | 3.36e-03 | Protein ratios | Myeloid | 5 | 4 | 6 | 14 | |
| 5006 | ESAM/PDGFB ratio | PRORT001064 | 3.35e-03 | Protein ratios | Hepatocyte | 8 | 2 | 9 | 28 | |
| 5007 | SPINT1/SUSD2 ratio | PRORT001810 | 3.27e-03 | Protein ratios | B / plasma cell | 20 | 1 | 6 | 7 | |
| 5008 | PACS2 levels | PROLV001482 | 3.27e-03 | Protein levels | Stromal / connective | 1 | 1 | 5 | 25 | |
| 5009 | ENPP7 levels | PROLV000711 | 3.24e-03 | Protein levels | Hepatocyte | 60 | 2 | 10 | 22 | |
| 5010 | Breast disorder | BREAS000002 | 3.20e-03 | Breast | Respiratory epithelium | 0 | 0 | 11 | 13 | |
| 5011 | Lactase deficiency | METBL000002 | 3.19e-03 | Metabolic | Vascular | 0 | 2 | 5 | 12 | |
| 5012 | CDH5/LGALS4 ratio | PRORT000557 | 3.19e-03 | Protein ratios | Hepatocyte | 22 | 1 | 5 | 2 | |
| 5013 | TPPP3 levels | PROLV002098 | 3.17e-03 | Protein levels | Muscle / cardiac | 4 | 2 | 4 | 8 | |
| 5014 | CXCL5/SERPINE1 ratio | PRORT000832 | 3.14e-03 | Protein ratios | Myeloid | 0 | 5 | 10 | 14 | |
| 5015 | Retinal morphology | OPHTH000041 | 3.08e-03 | Ophthalmic | Melanocyte | 0 | 1 | 4 | 5 | |
| 5016 | GABBR2 levels | PROLV000845 | 3.07e-03 | Protein levels | B / plasma cell | 0 | 2 | 4 | 9 | |
| 5017 | CLK2 levels | PROLV000460 | 2.99e-03 | Protein levels | Hepatocyte | 11 | 2 | 7 | 20 | |
| 5018 | Whole body impedance | BCOMP000007 | 2.97e-03 | Body composition | Stromal / connective | 553 | 5 | 7 | 15 | |
| 5019 | Benign neoplasm, Salivary gland | MALIG000006 | 2.88e-03 | Malignancy | Neural / glial | 1 | 1 | 4 | 11 | |
| 5020 | Gut microbial abundance, Chromatiales | GASTR000024 | 2.87e-03 | Gastrointestinal | Lymphocyte | 0 | 2 | 9 | 20 | |
| 5021 | RUVBL1 levels | PROLV001764 | 2.87e-03 | Protein levels | B / plasma cell | 8 | 1 | 5 | 6 | |
| 5022 | EPHB4/ESAM ratio | PRORT001036 | 2.86e-03 | Protein ratios | Vascular | 32 | 3 | 10 | 22 | |
| 5023 | Steatohepatitis, nonalcoholic | HPBIL000032 | 2.83e-03 | Hepatopancreatobiliary | Renal epithelium | 0 | 0 | 5 | 7 | |
| 5024 | Gut microbial abundance, CAG-269 | GASTR000021 | 2.81e-03 | Gastrointestinal | Lymphocyte | 0 | 1 | 4 | 7 | |
| 5025 | BAIAP2/MME ratio | PRORT000203 | 2.81e-03 | Protein ratios | Hepatocyte | 15 | 1 | 6 | 6 | |
| 5026 | CCS levels | PROLV000307 | 2.79e-03 | Protein levels | Lymphocyte | 50 | 2 | 13 | 44 | |
| 5027 | GIPC2 levels | PROLV000888 | 2.77e-03 | Protein levels | Hepatocyte | 4 | 2 | 5 | 11 | |
| 5028 | PDCD5 levels | PROLV001517 | 2.76e-03 | Protein levels | Lymphocyte | 4 | 3 | 14 | 25 | |
| 5029 | PIKFYVE levels | PROLV001559 | 2.74e-03 | Protein levels | Lymphocyte | 3 | 2 | 11 | 31 | |
| 5030 | Blood urea nitrogen | NEPHR000017 | 2.73e-03 | Nephrourologic | Renal epithelium | 631 | 0 | 3 | 6 | |
| 5031 | BSG levels | PROLV000214 | 2.72e-03 | Protein levels | Hepatocyte | 82 | 2 | 6 | 9 | |
| 5032 | CPB1/REG1B ratio | PRORT000729 | 2.71e-03 | Protein ratios | Hepatocyte | 30 | 1 | 5 | 5 | |
| 5033 | SCARA5/TNC ratio | PRORT001760 | 2.69e-03 | Protein ratios | Granulosa cell | 39 | 2 | 9 | 13 | |
| 5034 | SCRG1 levels | PROLV001793 | 2.66e-03 | Protein levels | Stromal / connective | 1 | 0 | 6 | 7 | |
| 5035 | CRKL/PLA2G4A ratio | PRORT000766 | 2.64e-03 | Protein ratios | Hepatocyte | 7 | 2 | 10 | 16 | |
| 5036 | RILPL2 levels | PROLV001735 | 2.53e-03 | Protein levels | Muscle / cardiac | 10 | 5 | 8 | 19 | |
| 5037 | PPP2R2A levels | PROLV001618 | 2.51e-03 | Protein levels | Lymphocyte | 0 | 3 | 9 | 29 | |
| 5038 | FUT8/SPARC ratio | PRORT001190 | 2.49e-03 | Protein ratios | Lymphocyte | 1 | 1 | 10 | 24 | |
| 5039 | PER3 levels | PROLV001537 | 2.47e-03 | Protein levels | Muscle / cardiac | 5 | 3 | 10 | 17 | |
| 5040 | SCGN levels | PROLV001789 | 2.47e-03 | Protein levels | Gastrointestinal epithelium | 12 | 0 | 6 | 12 | |
| 5041 | Beta-cell function | METBL000036 | 2.45e-03 | Metabolic | Neural / glial | 0 | 1 | 5 | 13 | |
| 5042 | MED18/ZBTB16 ratio | PRORT001512 | 2.44e-03 | Protein ratios | Muscle / cardiac | 10 | 1 | 3 | 13 | |
| 5043 | DNPH1/NSFL1C ratio | PRORT000935 | 2.43e-03 | Protein ratios | Lymphocyte | 0 | 1 | 4 | 10 | |
| 5044 | Bicarbonate | METAB000042 | 2.40e-03 | Metabolites | Renal epithelium | 656 | 1 | 6 | 6 | |
| 5045 | LRRC37A2 levels | PROLV001233 | 2.39e-03 | Protein levels | B / plasma cell | 17 | 2 | 13 | 27 | |
| 5046 | CTRB1/PLA2G1B ratio | PRORT000795 | 2.38e-03 | Protein ratios | Pancreatic epithelium | 18 | 0 | 2 | 6 | |
| 5047 | ACAA1 levels | PROLV000008 | 2.37e-03 | Protein levels | Hepatocyte | 14 | 1 | 10 | 8 | |
| 5048 | Healthspan | AGING000004 | 2.31e-03 | Aging | Hepatocyte | 12 | 1 | 12 | 12 | |
| 5049 | RAD23B levels | PROLV001703 | 2.30e-03 | Protein levels | Stromal / connective | 1 | 4 | 9 | 14 | |
| 5050 | PAPL levels | PROLV001494 | 2.21e-03 | Protein levels | Melanocyte | 0 | 3 | 11 | 12 | |
| 5051 | Diabetes, secondary | METBL000032 | 2.20e-03 | Metabolic | Neural / glial | 0 | 2 | 10 | 24 | |
| 5052 | NMNAT1 levels | PROLV001411 | 2.20e-03 | Protein levels | Lymphocyte | 18 | 1 | 10 | 26 | |
| 5053 | PADI4 levels | PROLV001484 | 2.18e-03 | Protein levels | B / plasma cell | 1 | 4 | 15 | 26 | |
| 5054 | Arm mass | BCOMP000014 | 2.14e-03 | Body composition | Stromal / connective | 302 | 4 | 9 | 13 | |
| 5055 | AXIN1/BACH1 ratio | PRORT000164 | 2.05e-03 | Protein ratios | Hepatocyte | 13 | 4 | 11 | 22 | |
| 5056 | Hospital discharge | MISCL000023 | 2.03e-03 | Miscellaneous | Lymphocyte | 2 | 1 | 10 | 39 | |
| 5057 | SPESP1 levels | PROLV001926 | 2.01e-03 | Protein levels | Lymphocyte | 3 | 3 | 11 | 18 | |
| 5058 | Tubulointerstitial kidney disease | NEPHR000025 | 2.01e-03 | Nephrourologic | Lymphocyte | 2 | 0 | 8 | 17 | |
| 5059 | PDP1 levels | PROLV001530 | 1.99e-03 | Protein levels | Hepatocyte | 0 | 0 | 2 | 6 | |
| 5060 | Sleep behaviour | BEHAV000016 | 1.98e-03 | Behavioural | Neural / glial | 57 | 4 | 8 | 7 | |
| 5061 | STX6 levels | PROLV001969 | 1.94e-03 | Protein levels | Lymphocyte | 0 | 3 | 10 | 16 | |
| 5062 | PMVK/PRTFDC1 ratio | PRORT001693 | 1.94e-03 | Protein ratios | Muscle / cardiac | 1 | 2 | 11 | 12 | |
| 5063 | Digital deformity | MSKEL000053 | 1.92e-03 | Musculoskeletal | Stromal / connective | 0 | 5 | 8 | 33 | |
| 5064 | Pyrimidine metabolites | METAB000063 | 1.90e-03 | Metabolites | Granulosa cell | 0 | 1 | 7 | 16 | |
| 5065 | Cervical intraepithelial lesion | REPRO000002 | 1.85e-03 | Reproductive | Lymphocyte | 23 | 2 | 11 | 25 | |
| 5066 | SEPHS1 levels | PROLV001812 | 1.83e-03 | Protein levels | Neural / glial | 0 | 2 | 6 | 8 | |
| 5067 | MAP3K5/ZBTB16 ratio | PRORT001489 | 1.83e-03 | Protein ratios | Muscle / cardiac | 10 | 5 | 9 | 25 | |
| 5068 | CTRC/KIRREL2 ratio | PRORT000796 | 1.79e-03 | Protein ratios | B / plasma cell | 14 | 0 | 1 | 5 | |
| 5069 | WFIKKN1 levels | PROLV002191 | 1.79e-03 | Protein levels | Vascular | 125 | 2 | 7 | 15 | |
| 5070 | CKAP4/LTBR ratio | PRORT000622 | 1.76e-03 | Protein ratios | Muscle / cardiac | 17 | 1 | 6 | 18 | |
| 5071 | DSG4 levels | PROLV000657 | 1.75e-03 | Protein levels | Cutaneous epithelium | 24 | 1 | 7 | 10 | |
| 5072 | Premalignant lesion, Cervix | MALIG000036 | 1.75e-03 | Malignancy | Lymphocyte | 36 | 1 | 8 | 27 | |
| 5073 | Urinary tract infection | IMMUN000074 | 1.74e-03 | Immunologic | Neural / glial | 1 | 1 | 3 | 7 | |
| 5074 | Trunk mass | BCOMP000019 | 1.68e-03 | Body composition | Stromal / connective | 381 | 4 | 10 | 14 | |
| 5075 | Gut microbial abundance, Staphylococcus | GASTR000036 | 1.65e-03 | Gastrointestinal | Lymphocyte | 0 | 1 | 6 | 11 | |
| 5076 | Tympanic membrane perforation | AUDIO000019 | 1.64e-03 | Auditory | Stromal / connective | 5 | 3 | 6 | 8 | |
| 5077 | PIK3IP1 levels | PROLV001558 | 1.63e-03 | Protein levels | Vascular | 31 | 0 | 4 | 9 | |
| 5078 | CA1/TGM2 ratio | PRORT000270 | 1.62e-03 | Protein ratios | Hematopoietic progenitor | 1 | 6 | 9 | 12 | |
| 5079 | GGT1/MME ratio | PRORT001214 | 1.59e-03 | Protein ratios | Hepatocyte | 39 | 1 | 5 | 12 | |
| 5080 | CDSN/WFDC12 ratio | PRORT000585 | 1.57e-03 | Protein ratios | Lymphocyte | 41 | 3 | 12 | 32 | |
| 5081 | Multiple system atrophy | NEURO000020 | 1.53e-03 | Neurologic | Neural / glial | 0 | 3 | 6 | 16 | |
| 5082 | Pyruvate | METAB000069 | 1.51e-03 | Metabolites | Hematopoietic progenitor | 6 | 1 | 3 | 6 | |
| 5083 | LCN15 levels | PROLV001191 | 1.51e-03 | Protein levels | Gastrointestinal epithelium | 4 | 0 | 4 | 8 | |
| 5084 | Trunk fat percentage | BCOMP000018 | 1.50e-03 | Body composition | Neural / glial | 276 | 3 | 10 | 17 | |
| 5085 | Optic cup area | OPHTH000028 | 1.49e-03 | Ophthalmic | Vascular | 5 | 3 | 9 | 14 | |
| 5086 | DOK1 levels | PROLV000641 | 1.47e-03 | Protein levels | Stromal / connective | 6 | 2 | 5 | 14 | |
| 5087 | Serine | METAB000029 | 1.44e-03 | Metabolites | Epithelial | 1 | 4 | 13 | 17 | |
| 5088 | Oestrogen metabolite | ENDOC000009 | 1.35e-03 | Endocrine | Hepatocyte | 6 | 2 | 8 | 12 | |
| 5089 | GKN2 levels | PROLV000892 | 1.35e-03 | Protein levels | Neural / glial | 14 | 0 | 5 | 4 | |
| 5090 | CTSE levels | PROLV000563 | 1.34e-03 | Protein levels | Gastrointestinal epithelium | 50 | 0 | 5 | 6 | |
| 5091 | FABP1/LGALS4 ratio | PRORT001095 | 1.32e-03 | Protein ratios | Hepatocyte | 27 | 1 | 9 | 21 | |
| 5092 | Sciatica | NEURO000033 | 1.31e-03 | Neurologic | Neural / glial | 12 | 6 | 11 | 26 | |
| 5093 | Forced expiratory volume, FEV | RESPI000019 | 1.27e-03 | Respiratory | Stromal / connective | 370 | 1 | 5 | 13 | |
| 5094 | CD160 levels | PROLV000311 | 1.25e-03 | Protein levels | Lymphocyte | 78 | 2 | 11 | 17 | |
| 5095 | Alanine metabolite | METAB000001 | 1.25e-03 | Metabolites | Gastrointestinal epithelium | 0 | 2 | 9 | 7 | |
| 5096 | HDLBP levels | PROLV000960 | 1.22e-03 | Protein levels | Hepatocyte | 0 | 1 | 4 | 9 | |
| 5097 | GGT1 levels | PROLV000883 | 1.20e-03 | Protein levels | Hepatocyte | 87 | 1 | 5 | 7 | |
| 5098 | COL24A1 levels | PROLV000486 | 1.20e-03 | Protein levels | Stromal / connective | 2 | 5 | 10 | 25 | |
| 5099 | Medication, sleep apnoea | RESPI000008 | 1.20e-03 | Respiratory | Cutaneous epithelium | 0 | 1 | 8 | 15 | |
| 5100 | TGFBR2 levels | PROLV002022 | 1.17e-03 | Protein levels | Renal epithelium | 62 | 0 | 3 | 4 | |
| 5101 | TGFBR2/TNFRSF19 ratio | PRORT001834 | 1.16e-03 | Protein ratios | Neural / glial | 12 | 3 | 7 | 13 | |
| 5102 | Height | BMORP000009 | 1.14e-03 | Body morphology | Stromal / connective | 3,280 | 3 | 4 | 6 | |
| 5103 | CDH5/ENG ratio | PRORT000556 | 1.13e-03 | Protein ratios | Vascular | 30 | 2 | 8 | 14 | |
| 5104 | CD79B levels | PROLV000356 | 1.12e-03 | Protein levels | B / plasma cell | 22 | 1 | 6 | 5 | |
| 5105 | NCR3 levels | PROLV001383 | 1.11e-03 | Protein levels | Adipose | — | 3 | 10 | 28 | |
| 5106 | GUCA2A levels | PROLV000945 | 1.00e-03 | Protein levels | Pancreatic epithelium | 28 | 0 | 5 | 5 | |
| 5107 | SMAD2 levels | PROLV001895 | 1.00e-03 | Protein levels | Stromal / connective | 0 | 1 | 4 | 8 | |
| 5108 | SERPINA5 levels | PROLV001819 | 9.99e-04 | Protein levels | Hepatocyte | 98 | 1 | 5 | 10 | |
| 5109 | CSF2RB levels | PROLV000539 | 9.96e-04 | Protein levels | Lymphocyte | 10 | 2 | 6 | 24 | |
| 5110 | Social activity, none | SOCIO000018 | 9.86e-04 | Socioeconomic | Neural / glial | 3 | 4 | 14 | 27 | |
| 5111 | HLA-E levels | PROLV000976 | 9.81e-04 | Protein levels | Stromal / connective | 104 | 1 | 7 | 30 | |
| 5112 | Paroxysmal neurological disorder | NEURO000035 | 9.81e-04 | Neurologic | Neural / glial | 21 | 3 | 4 | 10 | |
| 5113 | Aortic diameter | VASCU000052 | 9.71e-04 | Vascular | Muscle / cardiac | 215 | 5 | 7 | 19 | |
| 5114 | SLURP1 levels | PROLV001893 | 9.67e-04 | Protein levels | Cutaneous epithelium | 1 | 0 | 8 | 6 | |
| 5115 | Nephritis | NEPHR000024 | 9.64e-04 | Nephrourologic | Hepatocyte | 24 | 0 | 5 | 9 | |
| 5116 | KYAT1 levels | PROLV001169 | 9.45e-04 | Protein levels | Neural / glial | 2 | 2 | 8 | 16 | |
| 5117 | LYPD8 levels | PROLV001253 | 9.17e-04 | Protein levels | Salivary epithelium | 6 | 1 | 5 | 6 | |
| 5118 | Benign prostatic hyperplasia | REPRO000011 | 9.02e-04 | Reproductive | Respiratory epithelium | 25 | 0 | 5 | 7 | |
| 5119 | TRIM40 levels | PROLV002109 | 8.84e-04 | Protein levels | Muscle / cardiac | 52 | 4 | 10 | 9 | |
| 5120 | NTF4 levels | PROLV001443 | 8.50e-04 | Protein levels | Muscle / cardiac | 0 | 2 | 8 | 11 | |
| 5121 | ECHDC3 levels | PROLV000670 | 8.49e-04 | Protein levels | Hepatocyte | 45 | 2 | 7 | 7 | |
| 5122 | Creativity | PSYCH000003 | 8.34e-04 | Psychiatric | Neural / glial | 10 | 4 | 13 | 23 | |
| 5123 | Physical function | MISCL000041 | 8.28e-04 | Miscellaneous | Stromal / connective | 502 | 3 | 4 | 9 | |
| 5124 | BCR/CLIP2 ratio | PRORT000222 | 7.97e-04 | Protein ratios | Epithelial | 1 | 1 | 7 | 5 | |
| 5125 | Cholecystitis | HPBIL000008 | 7.87e-04 | Hepatopancreatobiliary | Hepatocyte | 18 | 2 | 7 | 7 | |
| 5126 | CRISP2 levels | PROLV000524 | 7.82e-04 | Protein levels | Lymphocyte | 3 | 1 | 9 | 12 | |
| 5127 | Macular puckering of retina | OPHTH000037 | 7.71e-04 | Ophthalmic | Stromal / connective | 17 | 3 | 8 | 11 | |
| 5128 | CD27/DLL1 ratio | PRORT000412 | 7.67e-04 | Protein ratios | B / plasma cell | 15 | 3 | 9 | 19 | |
| 5129 | CLPP/DECR1 ratio | PRORT000672 | 7.60e-04 | Protein ratios | B / plasma cell | 0 | 4 | 9 | 10 | |
| 5130 | DECR1/METAP1D ratio | PRORT000883 | 7.46e-04 | Protein ratios | Muscle / cardiac | 0 | 1 | 5 | 13 | |
| 5131 | CTRB1/KIRREL2 ratio | PRORT000794 | 7.31e-04 | Protein ratios | Pancreatic epithelium | 27 | 0 | 2 | 7 | |
| 5132 | CRACR2A/IRAG2 ratio | PRORT000740 | 7.30e-04 | Protein ratios | Hepatocyte | 1 | 3 | 11 | 37 | |
| 5133 | Body size, adult | BMORP000003 | 7.02e-04 | Body morphology | Stromal / connective | 300 | 3 | 6 | 8 | |
| 5134 | Lean mass | BCOMP000009 | 6.91e-04 | Body composition | Stromal / connective | 897 | 4 | 7 | 8 | |
| 5135 | RGCC levels | PROLV001727 | 6.90e-04 | Protein levels | Stromal / connective | 1 | 2 | 4 | 9 | |
| 5136 | ATXN10/CASP10 ratio | PRORT000161 | 6.85e-04 | Protein ratios | Granulosa cell | 1 | 4 | 9 | 24 | |
| 5137 | CDHR2 levels | PROLV000379 | 6.82e-04 | Protein levels | Hepatocyte | 103 | 2 | 13 | 22 | |
| 5138 | PRR15 levels | PROLV001641 | 6.75e-04 | Protein levels | Epithelial | 0 | 2 | 6 | 9 | |
| 5139 | YBX1 levels | PROLV002204 | 6.56e-04 | Protein levels | Muscle / cardiac | 0 | 2 | 8 | 25 | |
| 5140 | Sleep-related movement disorder | NEURO000016 | 6.52e-04 | Neurologic | Pancreatic epithelium | 4 | 0 | 8 | 5 | |
| 5141 | Tumour marker CA125 | MALIG000037 | 6.44e-04 | Malignancy | Melanocyte | 0 | 5 | 12 | 27 | |
| 5142 | CC2D1A/WWP2 ratio | PRORT000331 | 6.36e-04 | Protein ratios | Stromal / connective | 0 | 0 | 4 | 5 | |
| 5143 | Endocrine gland disorder | ENDOC000003 | 6.12e-04 | Endocrine | Neural / glial | 0 | 3 | 5 | 13 | |
| 5144 | Family history, chronic disease | MISCL000009 | 5.99e-04 | Miscellaneous | Vascular | 0 | 5 | 13 | 8 | |
| 5145 | Fasciectomy | MSKEL000045 | 5.76e-04 | Musculoskeletal | Stromal / connective | 11 | 3 | 8 | 14 | |
| 5146 | Basal metabolic rate | METBL000007 | 5.74e-04 | Metabolic | Neural / glial | 298 | 6 | 10 | 20 | |
| 5147 | SFRP2 levels | PROLV001845 | 5.49e-04 | Protein levels | Neural / glial | 11 | 4 | 8 | 24 | |
| 5148 | ARHGAP25/RNF41 ratio | PRORT000139 | 5.38e-04 | Protein ratios | Lymphocyte | 0 | 4 | 13 | 28 | |
| 5149 | MCAM/NCAM1 ratio | PRORT001505 | 5.38e-04 | Protein ratios | Adipose | 14 | 4 | 6 | 17 | |
| 5150 | S100G levels | PROLV001772 | 5.38e-04 | Protein levels | Hepatocyte | 9 | 1 | 3 | 10 | |
| 5151 | SPINK1 levels | PROLV001927 | 5.24e-04 | Protein levels | Pancreatic epithelium | 75 | 0 | 6 | 9 | |
| 5152 | Biliary cirrhosis | HPBIL000005 | 5.06e-04 | Hepatopancreatobiliary | Salivary epithelium | — | 0 | 12 | 10 | |
| 5153 | CTRB1 levels | PROLV000557 | 5.03e-04 | Protein levels | Pancreatic epithelium | 159 | 0 | 3 | 4 | |
| 5154 | Leg impedance | BCOMP000016 | 4.97e-04 | Body composition | Stromal / connective | 562 | 4 | 7 | 19 | |
| 5155 | TRAF3 levels | PROLV002100 | 4.95e-04 | Protein levels | B / plasma cell | 18 | 2 | 14 | 29 | |
| 5156 | APP/NID2 ratio | PRORT000129 | 4.75e-04 | Protein ratios | Stromal / connective | 0 | 2 | 6 | 11 | |
| 5157 | BTN2A1/SPINT2 ratio | PRORT000261 | 4.66e-04 | Protein ratios | Hepatocyte | 30 | 2 | 9 | 16 | |
| 5158 | Narcolepsy | NEURO000036 | 4.65e-04 | Neurologic | Neural / glial | 17 | 4 | 13 | 30 | |
| 5159 | PEAR1/SPINT2 ratio | PRORT001660 | 4.58e-04 | Protein ratios | Platelet | 3 | 2 | 6 | 20 | |
| 5160 | Sepsis | IMMUN000071 | 4.51e-04 | Immunologic | Vascular | — | 1 | 6 | 7 | |
| 5161 | CRKL/DBNL ratio | PRORT000762 | 4.22e-04 | Protein ratios | Muscle / cardiac | 2 | 5 | 11 | 23 | |
| 5162 | Psychiatric disorder | PSYCH000016 | 4.21e-04 | Psychiatric | Neural / glial | 0 | 2 | 7 | 11 | |
| 5163 | Lens disorder | OPHTH000013 | 4.19e-04 | Ophthalmic | Stromal / connective | 3 | 5 | 8 | 10 | |
| 5164 | PCOLCE levels | PROLV001510 | 3.96e-04 | Protein levels | Neural / glial | 1 | 2 | 6 | 14 | |
| 5165 | Urbanicity | SOCIO000029 | 3.89e-04 | Socioeconomic | Melanocyte | 0 | 3 | 9 | 12 | |
| 5166 | Alport syndrome | NEPHR000003 | 3.85e-04 | Nephrourologic | Lymphocyte | 3 | 3 | 4 | 20 | |
| 5167 | ATXN10/SLC27A4 ratio | PRORT000163 | 3.77e-04 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 5168 | FAM3C levels | PROLV000767 | 3.76e-04 | Protein levels | Hepatocyte | 14 | 1 | 4 | 14 | |
| 5169 | Gut microbial abundance, Massiliomicrobiota | GASTR000028 | 3.67e-04 | Gastrointestinal | Renal epithelium | 0 | 0 | 8 | 8 | |
| 5170 | Cancer, Prostate | MALIG000026 | 3.29e-04 | Malignancy | Gastrointestinal epithelium | 330 | 1 | 7 | 10 | |
| 5171 | JAM2 levels | PROLV001124 | 3.28e-04 | Protein levels | Vascular | 4 | 0 | 5 | 7 | |
| 5172 | Body water mass | BCOMP000006 | 3.23e-04 | Body composition | Stromal / connective | 324 | 5 | 10 | 21 | |
| 5173 | Liver enzyme levels, GGT | HPBIL000015 | 3.20e-04 | Hepatopancreatobiliary | Hepatocyte | 1,720 | 1 | 7 | 10 | |
| 5174 | COL15A1 levels | PROLV000483 | 3.17e-04 | Protein levels | Stromal / connective | 4 | 0 | 6 | 11 | |
| 5175 | PPP1R14A levels | PROLV001614 | 3.14e-04 | Protein levels | Neural / glial | 11 | 2 | 7 | 11 | |
| 5176 | HNRNPAB levels | PROLV000981 | 3.12e-04 | Protein levels | Granulosa cell | 11 | 3 | 8 | 17 | |
| 5177 | Peak expiratory flow | RESPI000023 | 3.07e-04 | Respiratory | Stromal / connective | 305 | 2 | 5 | 8 | |
| 5178 | C21orf58 levels | PROLV000231 | 3.05e-04 | Protein levels | Hepatocyte | 0 | 4 | 10 | 17 | |
| 5179 | HAO1 levels | PROLV000951 | 2.97e-04 | Protein levels | Hepatocyte | 87 | 1 | 6 | 9 | |
| 5180 | LY6D levels | PROLV001246 | 2.79e-04 | Protein levels | Respiratory epithelium | 19 | 1 | 10 | 6 | |
| 5181 | Consultant specialty, trauma and orthopaedics | MISCL000019 | 2.44e-04 | Miscellaneous | Stromal / connective | 2 | 5 | 15 | 14 | |
| 5182 | PDZK1 levels | PROLV001531 | 2.42e-04 | Protein levels | Hepatocyte | 27 | 3 | 12 | 25 | |
| 5183 | CEACAM1/GGT1 ratio | PRORT000586 | 2.37e-04 | Protein ratios | Hepatocyte | 33 | 1 | 4 | 9 | |
| 5184 | Fat-free mass | BCOMP000008 | 2.30e-04 | Body composition | Stromal / connective | 273 | 6 | 9 | 12 | |
| 5185 | NTRK3/SCARF2 ratio | PRORT001604 | 2.30e-04 | Protein ratios | Vascular | 2 | 0 | 9 | 10 | |
| 5186 | GGT1/IL1RL2 ratio | PRORT001213 | 2.24e-04 | Protein ratios | Hepatocyte | 23 | 2 | 11 | 16 | |
| 5187 | Latent factor, red cell and basophil | HEMAT000037 | 2.21e-04 | Hematologic | Lymphocyte | 2 | 0 | 2 | 8 | |
| 5188 | Infective dermatitis | DERMA000012 | 2.13e-04 | Dermatologic | Lymphocyte | 8 | 3 | 14 | 18 | |
| 5189 | Food-related dermatitis | DERMA000011 | 2.09e-04 | Dermatologic | Lymphocyte | 0 | 0 | 9 | 19 | |
| 5190 | KIRREL2/PLA2G1B ratio | PRORT001406 | 2.06e-04 | Protein ratios | Hepatocyte | 32 | 1 | 6 | 19 | |
| 5191 | AMY2A levels | PROLV000090 | 2.05e-04 | Protein levels | Epithelial | 63 | 1 | 6 | 10 | |
| 5192 | SWAP70 levels | PROLV001983 | 2.01e-04 | Protein levels | Hepatocyte | 3 | 2 | 9 | 12 | |
| 5193 | Viral wart | IMMUN000079 | 1.99e-04 | Immunologic | Lymphocyte | 7 | 4 | 11 | 39 | |
| 5194 | Optic disc morphology | OPHTH000030 | 1.95e-04 | Ophthalmic | Vascular | 8 | 1 | 10 | 15 | |
| 5195 | CPB1 levels | PROLV000504 | 1.94e-04 | Protein levels | Pancreatic epithelium | 91 | 0 | 5 | 3 | |
| 5196 | Operation, reproductive | REPRO000042 | 1.84e-04 | Reproductive | Hepatocyte | 9 | 0 | 3 | 7 | |
| 5197 | Bile acid levels | HPBIL000016 | 1.82e-04 | Hepatopancreatobiliary | Hepatocyte | 12 | 1 | 5 | 10 | |
| 5198 | CELA3A/KIRREL2 ratio | PRORT000597 | 1.82e-04 | Protein ratios | Granulosa cell | 29 | 1 | 6 | 9 | |
| 5199 | Proline metabolites | METAB000013 | 1.80e-04 | Metabolites | Granulosa cell | 2 | 0 | 5 | 9 | |
| 5200 | Anaemia of chronic kidney disease | HEMAT000003 | 1.79e-04 | Hematologic | Hepatocyte | 4 | 3 | 7 | 14 | |
| 5201 | FAM3B levels | PROLV000766 | 1.78e-04 | Protein levels | Gastrointestinal epithelium | 66 | 0 | 6 | 7 | |
| 5202 | Fat mass | BCOMP000005 | 1.77e-04 | Body composition | Neural / glial | 607 | 3 | 8 | 21 | |
| 5203 | FGF2 levels | PROLV000794 | 1.76e-04 | Protein levels | Adipose | 20 | 2 | 4 | 16 | |
| 5204 | Deafness with mutism | AUDIO000010 | 1.75e-04 | Auditory | Hepatocyte | 0 | 1 | 9 | 18 | |
| 5205 | ARG1 levels | PROLV000134 | 1.64e-04 | Protein levels | Muscle / cardiac | 18 | 3 | 13 | 28 | |
| 5206 | Colonic and urogenital fistula | GASTR000010 | 1.64e-04 | Gastrointestinal | Lymphocyte | 1 | 1 | 3 | 18 | |
| 5207 | Vitiligo | IMMUN000046 | 1.63e-04 | Immunologic | Neural / glial | — | 0 | 3 | 6 | |
| 5208 | Fatty acids, stearic acid | LIPID000028 | 1.63e-04 | Lipids | Hepatocyte | 0 | 2 | 5 | 9 | |
| 5209 | Consultant specialty, urology | MISCL000020 | 1.56e-04 | Miscellaneous | Neural / glial | 3 | 0 | 8 | 6 | |
| 5210 | KRT19 levels | PROLV001166 | 1.51e-04 | Protein levels | Respiratory epithelium | 46 | 0 | 11 | 7 | |
| 5211 | Body size, childhood | BMORP000004 | 1.49e-04 | Body morphology | Neural / glial | 188 | 2 | 5 | 5 | |
| 5212 | CDON levels | PROLV000385 | 1.49e-04 | Protein levels | Granulosa cell | 4 | 5 | 10 | 14 | |
| 5213 | Frailty, multimorbidity | METBL000012 | 1.49e-04 | Metabolic | Vascular | 188 | 3 | 10 | 10 | |
| 5214 | IGFBPL1 levels | PROLV001034 | 1.47e-04 | Protein levels | Hepatocyte | 26 | 1 | 4 | 8 | |
| 5215 | Cancer, Endometrium | MALIG000014 | 1.42e-04 | Malignancy | Lymphocyte | 8 | 2 | 14 | 50 | |
| 5216 | CPA1/CTRC ratio | PRORT000720 | 1.37e-04 | Protein ratios | Pancreatic epithelium | 38 | 0 | 1 | 5 | |
| 5217 | PGA4 levels | PROLV001542 | 1.37e-04 | Protein levels | Pancreatic epithelium | 31 | 0 | 7 | 8 | |
| 5218 | Disability allowance | SOCIO000019 | 1.26e-04 | Socioeconomic | Neural / glial | 0 | 4 | 15 | 28 | |
| 5219 | Patellar disorder | MSKEL000018 | 1.25e-04 | Musculoskeletal | Neural / glial | 0 | 0 | 4 | 8 | |
| 5220 | Anaemia of chronic disease | HEMAT000002 | 1.22e-04 | Hematologic | Hepatocyte | 4 | 3 | 6 | 15 | |
| 5221 | Cancer, Small intestine | MALIG000029 | 1.03e-04 | Malignancy | Neural / glial | 1 | 1 | 5 | 6 | |
| 5222 | CPB1/CTRC ratio | PRORT000725 | 9.93e-05 | Protein ratios | Pancreatic epithelium | 39 | 0 | 2 | 4 | |
| 5223 | CPB1/CTRB1 ratio | PRORT000724 | 9.38e-05 | Protein ratios | Epithelial | 26 | 0 | 9 | 14 | |
| 5224 | CPB1/KIRREL2 ratio | PRORT000726 | 9.01e-05 | Protein ratios | Pancreatic epithelium | 30 | 0 | 3 | 5 | |
| 5225 | Adjustment disorder | PSYCH000051 | 8.77e-05 | Psychiatric | Neural / glial | 0 | 5 | 6 | 16 | |
| 5226 | Trigger finger | MSKEL000072 | 8.55e-05 | Musculoskeletal | Stromal / connective | 7 | 2 | 4 | 8 | |
| 5227 | CPA1 levels | PROLV000501 | 8.16e-05 | Protein levels | Pancreatic epithelium | 139 | 0 | 6 | 6 | |
| 5228 | Pancreas fat | HPBIL000028 | 8.16e-05 | Hepatopancreatobiliary | Adipose | 11 | 0 | 5 | 6 | |
| 5229 | Eye disorder, none | OPHTH000007 | 7.88e-05 | Ophthalmic | Neural / glial | — | 4 | 14 | 11 | |
| 5230 | PDGF-BB levels | PROLV001521 | 7.78e-05 | Protein levels | Stromal / connective | 0 | 2 | 2 | 5 | |
| 5231 | Vaccination | IMMUN000085 | 7.75e-05 | Immunologic | Neural / glial | 10 | 5 | 10 | 12 | |
| 5232 | Urea | METAB000060 | 7.59e-05 | Metabolites | Renal epithelium | 491 | 0 | 5 | 9 | |
| 5233 | Corns and callosities | DERMA000023 | 7.42e-05 | Dermatologic | Cutaneous epithelium | 3 | 0 | 3 | 3 | |
| 5234 | BCAM/CDH5 ratio | PRORT000206 | 6.78e-05 | Protein ratios | Vascular | 42 | 1 | 12 | 12 | |
| 5235 | CES3 levels | PROLV000407 | 6.75e-05 | Protein levels | Hepatocyte | 70 | 1 | 6 | 12 | |
| 5236 | CPA1/PRSS2 ratio | PRORT000722 | 6.45e-05 | Protein ratios | Pancreatic epithelium | 17 | 0 | 5 | 9 | |
| 5237 | Carbohydrate metabolites | METAB000035 | 6.19e-05 | Metabolites | Hepatocyte | 7 | 2 | 13 | 22 | |
| 5238 | TLR4 levels | PROLV002044 | 5.80e-05 | Protein levels | Lymphocyte | 0 | 1 | 6 | 23 | |
| 5239 | FABP1/FABP2 ratio | PRORT001094 | 5.50e-05 | Protein ratios | Hepatocyte | 10 | 2 | 6 | 16 | |
| 5240 | TFF2 levels | PROLV002013 | 5.05e-05 | Protein levels | Pancreatic epithelium | 17 | 1 | 2 | 5 | |
| 5241 | COL4A1 levels | PROLV000490 | 4.05e-05 | Protein levels | Hepatocyte | 117 | 3 | 10 | 16 | |
| 5242 | Leg mass | BCOMP000017 | 3.97e-05 | Body composition | Neural / glial | 384 | 5 | 10 | 15 | |
| 5243 | CELA3A/CTRC ratio | PRORT000596 | 3.17e-05 | Protein ratios | Gastrointestinal epithelium | 29 | 0 | 4 | 5 | |
| 5244 | CXADR levels | PROLV000574 | 2.82e-05 | Protein levels | Hepatocyte | 49 | 1 | 5 | 14 | |
| 5245 | TFF1 levels | PROLV002012 | 2.34e-05 | Protein levels | Salivary epithelium | 15 | 1 | 2 | 7 | |
| 5246 | CA2/TGM2 ratio | PRORT000278 | 2.29e-05 | Protein ratios | Epithelial | 17 | 3 | 7 | 15 | |
| 5247 | MUC13 levels | PROLV001351 | 2.00e-05 | Protein levels | Vascular | 23 | 1 | 10 | 14 | |
| 5248 | ADAM12 levels | PROLV000025 | 1.93e-05 | Protein levels | B / plasma cell | 2 | 2 | 6 | 12 | |
| 5249 | MEGF9/MET ratio | PRORT001513 | 1.89e-05 | Protein ratios | Hepatocyte | 46 | 1 | 5 | 7 | |
| 5250 | KIRREL2 levels | PROLV001144 | 1.63e-05 | Protein levels | Pancreatic epithelium | 77 | 0 | 1 | 6 | |
| 5251 | UNC5D levels | PROLV002141 | 1.63e-05 | Protein levels | Neural / glial | 0 | 1 | 7 | 30 | |
| 5252 | Disability allowance, none | SOCIO000016 | 1.43e-05 | Socioeconomic | Neural / glial | 0 | 4 | 18 | 26 | |
| 5253 | Knee morphology | MSKEL000024 | 1.32e-05 | Musculoskeletal | Stromal / connective | 0 | 4 | 7 | 17 | |
| 5254 | Addison disease | ENDOC000001 | 1.29e-05 | Endocrine | Lymphocyte | 56 | 0 | 4 | 15 | |
| 5255 | EDA2R levels | PROLV000673 | 1.29e-05 | Protein levels | B / plasma cell | 20 | 4 | 12 | 26 | |
| 5256 | CPA1/CTRB1 ratio | PRORT000719 | 1.23e-05 | Protein ratios | Pancreatic epithelium | 13 | 0 | 2 | 7 | |
| 5257 | LAMP3/PRSS8 ratio | PRORT001421 | 1.14e-05 | Protein ratios | Lymphocyte | 5 | 3 | 8 | 30 | |
| 5258 | PLA2G1B levels | PROLV001567 | 1.13e-05 | Protein levels | Pancreatic epithelium | 69 | 0 | 4 | 6 | |
| 5259 | ROBO2/SFTPD ratio | PRORT001746 | 1.11e-05 | Protein ratios | Neural / glial | 15 | 1 | 5 | 19 | |
| 5260 | CPB1/REG1A ratio | PRORT000728 | 9.57e-06 | Protein ratios | Hepatocyte | 39 | 1 | 4 | 5 | |
| 5261 | Chloride | METAB000044 | 8.92e-06 | Metabolites | Hepatocyte | 527 | 0 | 6 | 11 | |
| 5262 | Occupational respiratory symptoms | RESPI000030 | 7.96e-06 | Respiratory | Neural / glial | 0 | 1 | 4 | 11 | |
| 5263 | SDHB levels | PROLV001799 | 7.11e-06 | Protein levels | Stromal / connective | 36 | 1 | 9 | 13 | |
| 5264 | ROBO2/SCARF2 ratio | PRORT001745 | 6.58e-06 | Protein ratios | Adipose | 12 | 4 | 10 | 12 | |
| 5265 | Cancer, Ovary | MALIG000024 | 6.40e-06 | Malignancy | Gastrointestinal epithelium | 23 | 0 | 7 | 13 | |
| 5266 | CPA1/CPB1 ratio | PRORT000718 | 5.70e-06 | Protein ratios | Pancreatic epithelium | 32 | 0 | 1 | 3 | |
| 5267 | Lens replacement | OPHTH000025 | 5.65e-06 | Ophthalmic | Vascular | 12 | 2 | 13 | 17 | |
| 5268 | SEPTIN8 levels | PROLV001814 | 4.63e-06 | Protein levels | B / plasma cell | 0 | 2 | 8 | 24 | |
| 5269 | Frailty, disability | MISCL000038 | 4.23e-06 | Miscellaneous | Neural / glial | 3 | 3 | 10 | 4 | |
| 5270 | GSTT2B levels | PROLV000943 | 3.55e-06 | Protein levels | Muscle / cardiac | 20 | 2 | 5 | 11 | |
| 5271 | SERPINI2 levels | PROLV001837 | 3.28e-06 | Protein levels | Pancreatic epithelium | 137 | 0 | 2 | 3 | |
| 5272 | PNLIPRP1 levels | PROLV001592 | 3.24e-06 | Protein levels | Gastrointestinal epithelium | 89 | 1 | 4 | 7 | |
| 5273 | Psoriatic arthritis vs psoriasis | IMMUN000041 | 3.19e-06 | Immunologic | Neural / glial | 7 | 3 | 10 | 12 | |
| 5274 | COL6A3 levels | PROLV000492 | 2.29e-06 | Protein levels | Stromal / connective | 38 | 2 | 4 | 12 | |
| 5275 | DDR1/SFTPD ratio | PRORT000880 | 1.57e-06 | Protein ratios | Epithelial | 18 | 1 | 5 | 6 | |
| 5276 | Plant sterols | METAB000074 | 1.30e-06 | Metabolites | Hepatocyte | 6 | 2 | 4 | 14 | |
| 5277 | HMOX2 levels | PROLV000979 | 1.24e-06 | Protein levels | Muscle / cardiac | 52 | 2 | 7 | 13 | |
| 5278 | Prostate-specific antigen | REPRO000041 | 1.22e-06 | Reproductive | Salivary epithelium | 56 | 1 | 7 | 8 | |
| 5279 | Arm fat percentage | BCOMP000012 | 1.12e-06 | Body composition | Neural / glial | 328 | 4 | 7 | 13 | |
| 5280 | CD59 levels | PROLV000347 | 1.04e-06 | Protein levels | Muscle / cardiac | 31 | 3 | 6 | 9 | |
| 5281 | Leg fat percentage | BCOMP000015 | 7.56e-07 | Body composition | Neural / glial | 295 | 4 | 7 | 17 | |
| 5282 | Heart disease | CARDI000036 | 4.04e-07 | Cardiac | Muscle / cardiac | 66 | 4 | 8 | 25 | |
| 5283 | COQ7 levels | PROLV000498 | 3.34e-07 | Protein levels | Hepatocyte | 59 | 1 | 6 | 7 | |
| 5284 | TIGIT levels | PROLV002034 | 2.60e-07 | Protein levels | Lymphocyte | 28 | 2 | 15 | 23 | |
| 5285 | GAST levels | PROLV000857 | 1.62e-07 | Protein levels | Salivary epithelium | 17 | 0 | 6 | 9 | |
| 5286 | GPHA2 levels | PROLV000922 | 7.48e-08 | Protein levels | Stromal / connective | 9 | 0 | 2 | 3 | |
| 5287 | GPLD1 levels | PROLV000926 | 5.37e-08 | Protein levels | Lymphocyte | 0 | 1 | 4 | 8 | |
| 5288 | Chronic illness or disability | MISCL000004 | 2.04e-09 | Miscellaneous | Neural / glial | 10 | 5 | 14 | 24 |